Clin2
NCT07767435Possibly a fitNot yet recruiting

Comparing two medications for second-trimester abortion

Abortion Induced ComplicatedAbortion

This study compares two medications—letrozole plus misoprostol versus misoprostol alone—to see which is more effective for ending a pregnancy in the second trimester (14–20 weeks) after the fetus has stopped developing. The goal is to find a safer, more comfortable method for women who need this procedure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
80 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be a woman aged 18 to 45 years.
  • You must be between 14 and 20 weeks pregnant, confirmed by ultrasound.
  • The pregnancy must have stopped growing (missed abortion or fetal demise).
  • Your cervix must be closed and you must not have any tissue protruding from the cervix.
  • You must not have heart, kidney, bleeding disorders, or allergies to the study drugs.
  • Your BMI must be 35 or lower.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06502158Recruiting· Phase 1
Comparing two medications for second-trimester abortion

This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.

The Bronx, New York
NCT07109947Recruiting
Using Letrozole and Misoprostol for Miscarriage Care

This trial tests whether taking an aromatase inhibitor (letrozole) before misoprostol helps complete a miscarriage more effectively. It may offer a treatment option for people with a missed or early pregnancy loss.

Aswān
NCT07753655Not yet recruiting
Letrozole before misoprostol for missed abortion

This trial tests whether taking letrozole before misoprostol shortens the time needed to complete a missed abortion, which is when the pregnancy stops developing but the body hasn't expelled the tissue. If effective, it could reduce the waiting time and make the process more efficient.

NCT06733727Not yet recruiting
Comparing two drugs for silent miscarriage management

This trial compares the effectiveness of two medications (letrozole and mifepristone with misoprostol) to help the body pass pregnancy tissue after a silent miscarriage. It may help women who prefer medical treatment over waiting or surgery.

NCT07160855Recruiting· Phase 4
Adding letrozole to standard miscarriage treatment

This trial tests whether adding letrozole (a hormone pill) to misoprostol (a medicine to complete a miscarriage) works better than misoprostol alone for ending a missed miscarriage in early pregnancy. It aims to make the process safer and possibly faster.

Multan, Punjab Province
NCT05341817Recruiting· Phase 4
Letrozole or mifepristone before medication abortion

This study tests whether taking letrozole or mifepristone before medication helps the medical abortion work better for pregnancies up to 10 weeks. You may be asked to try another method (repeat medicine or a procedure) if the first treatment does not fully work.

Singapore

Hear when a new Abortion trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.